Corporate and Securities partner and global leader of Pillsbury’s Capital Markets and Public Companies practice, Davina Kaile has guided public companies and late-stage private companies across a wide range of sectors, including technology, e-commerce, life sciences, financial services and retail in many high-profile, multibillion- and multimillion-dollar deals.
Davina has extensive experience in capital markets transactions, IPOs, mergers and acquisitions and tender offers, reverse mergers, divestitures, going private transactions, SPAC and deSPAC transactions, SEC reporting and compliance, stockholder engagement and proxy matters, Section 16 and 13 reporting, and corporate governance and general corporate matters. She represents issuers, underwriters and placement agents in IPOs and follow-on offerings, shelf, registered direct, and confidentially marketed public offerings and other equity financing transactions, including Rights Offerings, PIPE, ATM, and equity line transactions, and represents acquirors, acquirees, and financial advisors in mergers and acquisitions, tender offers, strategic investments and divestitures, and de-SPAC transactions. Davina also has extensive experience advising on ‘33 and ‘34 Act reporting and compliance, proxy matters, stock exchange compliance and initiatives, and corporate governance issues, including in connection with the Sarbanes-Oxley Act and Dodd-Frank Act.